Genetics, prevalence, screening and confirmation of primary aldosteronism: a position statement and consensus of the Working Group on Endocrine Hypertension of The European Society of Hypertension.

@article{Mulatero2020GeneticsPS,
  title={Genetics, prevalence, screening and confirmation of primary aldosteronism: a position statement and consensus of the Working Group on Endocrine Hypertension of The European Society of Hypertension.},
  author={P. Mulatero and S. Monticone and J. Deinum and L. Amar and A. Prejbisz and M. Zennaro and F. Beuschlein and G. Rossi and T. Nishikawa and A. Morganti and T. Seccia and Yen-Hung Lin and F. Fallo and J. Widimsk{\'y}},
  journal={Journal of Hypertension},
  year={2020}
}
: Autonomous aldosterone overproduction represents the underlying condition of 5-10% of patients with arterial hypertension and carries a significant burden of mortality and morbidity. The diagnostic algorithm for primary aldosteronism is sequentially based on hormonal tests (screening and confirmation tests), followed by lateralization studies (adrenal CT scanning and adrenal venous sampling) to distinguish between unilateral and bilateral disease. Despite the recommendations of the Endocrine… Expand
Recent Development toward the Next Clinical Practice of Primary Aldosteronism: A Literature Review
TLDR
Recent progress in the following clinically important topics of PA are focused on: prevalence of PA and its subtypes, newly revealed histopathological classification of aldosterone-producing lesions, novel diagnostic biomarkers and prediction scores. Expand
Primary aldosteronism: considerations about the evaluation of the aldosterone to renin ratio during canrenone treatment
TLDR
Treatment with canrenone at doses that effectively controlled hypokalemia and blood pressure values did not preclude the diagnosis in PA patients, while the addition of the angiotensin type 1 receptor blocker olmesartan raised the false negative rate, reducing the ARR. Expand
Aldosterone-producing adenoma associated with non-suppressed renin: a case series
TLDR
In patients with a consistently non-suppressed renin further diagnostic workup for PA should be considered if clinical suspicion remains high, and strict control of factors known to influence the ARR is crucial to avoid false-negative results. Expand
Practice Recommendations for Diagnosis and Treatment of the Most Common Forms of Secondary Hypertension
TLDR
The aim of this minireview is to provide updated concise information on the screening, diagnosis, and management of the most common forms, including primary aldosteronism, renovascular hypertension, pheochromocytoma and paraganglioma, Cushing’s syndrome, and obstructive sleep apnea. Expand
Targeted Metabolomics as a Tool in Discriminating Endocrine From Primary Hypertension
TLDR
Targeted metabolomics identifies distinct metabolic pattern between primary hypertension (PHT) and EHT providing promising discriminating performance. Expand
The effect of medication on the aldosterone‐to‐renin ratio. A critical review of the literature
TLDR
It is concluded that several medications can affect the aldosterone‐to‐renin ratio (ARR), and standardization of the medications used during ARR measurement is advisable for a reliable and accurate interpretation. Expand
Time-Dependent Risk of Atrial Fibrillation in Patients With Primary Aldosteronism After Medical or Surgical Treatment Initiation
TLDR
The results suggest the risk of new-onset atrial fibrillation remained elevated up to 3 years in treated primary aldosteronism compared with essential hypertension, which declined to comparable risk in essential hypertension thereafter. Expand
Confounders of the aldosterone‐to‐renin ratio when used as a screening test in hypertensive patients: A critical analysis of the literature
TLDR
It is revealed that sex, age, posture, and sodium‐intake influence the ARR, whereas assay techniques do not, and race and body mass index have an uncertain effect on theARR. Expand
Quality of life in primary aldosteronism: A prospective observational study
TLDR
The aim of the study was to compare the quality of life of patients affected by PA to the QOL of patientsaffected by essential hypertension. Expand
Assessment of Anti-Hypertensive Drug Adherence by Serial Aldosterone-To-Renin Ratio Measurement
TLDR
Delta ARR (ΔARR), defined as relative change in ARR before and after treatment initiation, provided high accuracy for determination of therapeutic compliance, with an AUC of 0.900 at 2 weeks and 0.886 at 8 weeks, and is a powerful test, cheap and widely available to accurately identify the non-adherence to RAAS inhibitors treatment. Expand
...
1
2
...

References

SHOWING 1-10 OF 87 REFERENCES
Prevalence and Clinical Manifestations of Primary Aldosteronism Encountered in Primary Care Practice.
TLDR
It is demonstrated that PA is a frequent cause of secondary hypertension, even in the general population of patients with hypertension, and indicates that most of these patients should be screened for PA. Expand
MANAGEMENT OF ENDOCRINE DISEASE: The role of confirmatory tests in the diagnosis of primary aldosteronism.
TLDR
The present review focuses on the description of the different dynamic tests available for demonstrating autonomy of aldosterone secretion, on the performance and limitations of confirmatory tests and on possible strategies for PA diagnosis which may either include or avoid the confirmatory step. Expand
Evaluation of primary aldosteronism
TLDR
This review summarizes current knowledge on diagnosis and treatment of primary aldosteronism, the most frequent cause of endocrine hypertension, highlighting the central role of the new guidelines and the diagnostic aspects still under debate. Expand
A prospective study of the prevalence of primary aldosteronism in 1,125 hypertensive patients.
TLDR
In newly diagnosed hypertensive patients referred to hypertension centers, the prevalence of APA is high (4.8%) and the availability of AVS is essential for an accurate identification of the adrenocortical pathologies underlying PA. Expand
New Advances in the Diagnostic Workup of Primary Aldosteronism
TLDR
Although the diagnostic approach to patients with primary aldosteronism remains a complex multistep process in which attention to detail is important, recent advances will improve patient care and outcomes. Expand
Case detection and diagnosis of primary aldosteronism - The consensus of Taiwan Society of Aldosteronism.
  • V. Wu, Ya-Hui Hu, +14 authors K. Wu
  • Medicine
  • Journal of the Formosan Medical Association = Taiwan yi zhi
  • 2017
TLDR
This Taiwan PA consensus is reached to raise more awareness of PA among medical professionals and hypertensive patients in Taiwan, and to facilitate reconciliation of better detection, identification and treatment of patients with PA. Expand
The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline.
TLDR
This guideline recommends that all patients with primary aldosteronism undergo adrenal computed tomography as the initial study in subtype testing and to exclude adrenocortical carcinoma and advises that an experienced radiologist should establish/exclude unilateral primary aldehydes using bilateral adrenal venous sampling. Expand
The Spectrum of Subclinical Primary Aldosteronism and Incident Hypertension
TLDR
Recognizing a potentially milder and expanded continuum of renin-independent aldosteronism, one that originates in normotension and is associated with inappropriate MR activation, may allow mitigation of MR-mediated cardiovascular disease at an earlier stage. Expand
Is Primary Aldosteronism Still Largely Unrecognized?
TLDR
Clinical data obtained from "real-life" show that the screening rate for PA is much lower and PA remains an under-diagnosed and under-treated cause of secondary hypertension with an associated increased risk of cardio- and cerebrovascular mortality and morbidity. Expand
Management of adrenal incidentalomas: European Society of Endocrinology Clinical Practice Guideline in collaboration with the European Network for the Study of Adrenal Tumors.
TLDR
This guideline provides guidance on which surgical approach should be considered for adrenal masses with radiological findings suspicious of malignancy, and offers recommendations for the follow-up of patients with adrenal incidentalomas. Expand
...
1
2
3
4
5
...